Tag: India
AHPI West UP calls for adoption of ‘CIBIL-like’ framework for insurers
Healthcare Reform Takes Center Stage at AHPI’s Landmark West UP Summit
Thyrocare appoints Rajdeep Panwar as Chief Commercial Officer
Rajdeep brings extensive experience in P&L management, multi-market business expansion, strategic planning and scaling large, multi-centre diagnostic operations
Oncogenomics grew 16% year to date, with faster reporting timelines: Report
India’s Diagnostics Sector Sees Strong Shift Toward Preventive & Precision Testing in 2025
“Merck has made significant efforts to strengthen lab solutions and R&D...
Dhananjay Singh, Managing Director, Merck Life Science & Head of Science & Lab Solutions Commercial shares insights on the company’s latest offerings, technology trends, investment plans and upcoming initiatives
Arya.ag raises Rs 725 crore in Series D funding
The investment will enable Arya.ag to deepen its engagement with farmers and their organisations to promote climate-smart, market-led agriculture practices
Health Minister J P Nadda releases 10th edition of Indian pharmacopoeia
Indian Pharmacopoeia 2026 expands coverage of anti-TB, anti-diabetic and anti-cancer medicines with 121 new monographs
Ayushman Bharat at Scale: 180,000 Arogya Mandirs and 42 Crore Health...
The flagship programme combines preventive care, hospital coverage and digital health to strengthen India’s public health system
Govt strengthening university innovation ecosystem through Inclusive Technology Business Incubators: Dr...
Union Minister Dr. Jitendra Singh reviews DST-backed Inclusive Technology Business Incubator at Delhi Technological University, lauds university-led startup outcomes
2025 in Review, 2026 in Sight: How India’s life sciences &...
New Delhi: As India closes 2025, its healthcare, pharmaceutical, and biotechnology sectors reflect a year marked by resilience, structural alignment, and accelerating adoption of...
ICRA retains positive outlook on hospitals, stable on pharma
Hospital sector revenue seen growing 16-18% in FY2026; Pharma revenue projected to expand 9-11%